A bulk of studies have validated that metformin also promotes the cancer-killing functions of CD8+T cells in metabolic regulation-dependent manners (Pearce et al., 2009; Chen et al., 2021b; Chao et al., 2022). The gene discussed is CD8A; the disease is cancer.